The U.S. Food and Drug Administration cleared a new version of Abbott Laboratories’ continuous glucose monitoring device.

Researchers at Switzerland-based Empa, ETH Zurich and Zurich University Hospital developed a sensor that has the potential to identify SARS-CoV-2, the novel coronavirus that causes COVID-19, in the air.

Early detection of cardiovascular disease is becoming possible due to research from Giovanna Guidoboni, Marjorie Skubic and a team at the University of Missouri.

The Bill & Melinda Gates Foundation and Jeff Bezos’ Day One Fund teamed up to donate $15 million to the Diagnostics Accelerator as part of the Alzheimer’s Drug Discovery Foundation.

For a while now there has been a heated debate surrounding hybrid and closed loop insulin systems.